Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome-Reference-Cited by-同舟云学术

Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome

Published:2015-10 Issue:10 Volume:21 Page:1761-1769
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Pusic Iskra,Choi Jaebok,Fiala Mark A.,Gao Feng,Holt Matthew,Cashen Amanda F.,Vij Ravi,Abboud Camille N.,Stockerl-Goldstein Keith E.,Jacoby Meghan A.,Uy Geoffrey L.,Westervelt Peter,DiPersio John F.

Funder

Washington University Institute of Clinical and Translational Sciences

National Center for Advancing Translational Sciences

National Institutes of Health

National Cancer Institute

National Cancer Institute Cancer Center Support

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference45 articles.

1. Total body irradiation-based myeloablative haploidentical stem cell transplantation is a safe and effective alternative to unrelated donor transplantation in patients without matched sibling donors;Solomon;Biol Blood Marrow Transplant,2015

2. Effect of graft source on unrelated donor hemopoietic stem cell transplantation in adults with acute myeloid leukemia after reduced-intensity or nonmyeloablative conditioning: a study from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire;Malard;Biol Blood Marrow Transplant,2015

3. Significant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent era;Majhail;Biol Blood Marrow Transplant,2015

4. Stem cell transplantation with reduced-intensity conditioning regimens: A review of ten years experience with new transplant concepts and new therapeutic agents;Barrett;Leukemia,2006

5. Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromes;Duncan;Biol Blood Marrow Transplant,2015

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple small‐dose infusions of G‐CSF‐mobilized haploidentical lymphocytes after autologous haematopoietic stem cell transplantation for acute myeloid leukaemia;British Journal of Haematology;2024-07-07

2. Navigating Treatment Options and Communication in Relapsed Pediatric AML;American Society of Clinical Oncology Educational Book;2024-06

3. Post-Transplant Maintenance Therapy in Acute Myeloid Leukemia;Cancers;2024-05-26

4. Azacitidine and gemtuzumab ozogamicin as post-transplant maintenance therapy for high-risk hematologic malignancies;Bone Marrow Transplantation;2024-05-23

5. Advances in the management of higher-risk myelodysplastic syndromes: future prospects;Leukemia & Lymphoma;2024-05-07